Bristol Myers Squibb v. Apotex, Inc./DRL/Lupin — Represented BMS in multiple ANDA cases regarding Sprycel® (dasatinib) tablets—a cancer drug used to treat patients with chronic myelogenous leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia—against defendants Apotex, Teva, Lupin, and Dr. Reddy’s Laboratories. These cases settled on favorable terms for BMS. Kirkland is currently representing BMS regarding Sprycel® against Alembic.
Boehringer Ingelheim Pharmaceuticals Inc., et al. v. [16 Defendants] — Representing Boehringer Ingelheim in a patent infringement suit arising from defendants’ submissions of Abbreviated New Drug Applications (“ANDA”) to the Food and Drug Administration (“FDA”) seeking approval to manufacture and sell generic versions of Boehringer’s Jardiance® (empagliflozin) products used to treat type II diabetes.
Boehringer Ingelheim Pharmaceuticals, Inc. et al. v. [11 Defendants] — Representing Boehringer Ingelheim in a patent infringement suit arising from defendants’ submissions of ANDAs to the FDA seeking approval to manufacture and sell generic versions of Boehringer’s Tradjenta® (linagliptin) and Jentadueto® (linagliptin and metformin hydrochloride) tablets used to treat type II diabetes.
Par Pharmaceutical, Inc. et al v. Eagle Pharmaceuticals Inc. — Representing Eagle in a patent infringement suit arising from Eagle’s submission of an ANDA to the FDA seeking approval to manufacture and sell a generic vasopressin product.
Onyx Therapeutics, Inc. v. InnoPharma Inc. — Representing InnoPharma in a patent infringement suit arising from InnoPharma’s submission of an ANDA to the FDA seeking approval to manufacture and sell a generic carfilzomib product.
Impax v. Lannett — Represented Impax Laboratories and AstraZeneca in District Court ANDA patent litigation related to nasal spray for treatment of migraines at trial, obtaining judgment that all asserted patent claims were valid and infringed, and successfully defended the District Court’s decision at the Federal Circuit.
Butamax Advanced Biofuels LLC v. Gevo, Inc. — Representing Butamax in a patent infringement litigation relating to genetically modified yeast for the production of isobutanol.
Bristol Myers Squibb v. Apotex — Represented BMS in Hatch-Waxman patent infringement litigation regarding a cancer drug used to treat patients with chronic myelogenous leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia. The case was resolved by settlement on favorable terms for BMS.
Pfizer v. Sandoz — Represented Plaintiffs in Hatch-Waxman patent litigation against Sandoz regarding a cancer drug indicated for the treatment of renal cell carcinoma. The case was resolved by settlement on favorable terms for Pfizer.
JobDiva v. Monster — Represented JobDiva in a multi-patent infringement action involving internet searching technology.
Other Matters
Dupont v. Kolon Industries — As a law clerk at Kim & Chang, performed legal research regarding Korean and American patent legal issues, and translated Korean patents to English for a multi-national patent litigation.
